SynergyIB Investment exits NGeneBio stake, cutting holding to 0% from 5.26%

PUBT · 1d ago
SynergyIB Investment exits NGeneBio stake, cutting holding to 0% from 5.26%
  • SynergyIB Investment cut its stake in NGeneBio to 0 shares from 1,100,412 shares, eliminating a 5.26% holding.
  • The change was dated Sept. 18, 2026, tied to redemption of the company’s 4th convertible bond.
  • The filing listed the investment purpose as passive.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NGeneBio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008000696), on October 08, 2026, and is solely responsible for the information contained therein.